Sanofi says U.S. regulators reject MS treatment Lemtrada

PARIS (Reuters) - Sanofi said its Lemtrada multiple sclerosis treatment failed to win approval from U.S. regulators to launch in the world's biggest drug market.

via Reuters: Health News Read More Here..